6hon MSN
Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication
Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best emerging technology stocks to invest in. On December 8, Sana Biotechnology announced the publication of groundbreaking preclinical data in the ...
Cathie Wood has seldom shied away from letting everyone know where she believes the next wave of market-changing businesses ...
Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.
Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.
CRISPR biosensors enable real-time health monitoring with attomolar sensitivity, wearable integration, and multiplex ...
A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...
Earlier in the week, ARK purchased 10,353 shares of CRISPR on Wednesday, valued at $584,530, and 43,333 shares on Tuesday, totaling $2,509,414. This consistent buying pattern suggests a strong ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Eli Lilly has struck a deal to buy Crispr gene-editing start-up Verve Therapeutics for up to $1.3bn, the latest ...
Inside cells, DNA twists and coils itself into a variety of different secondary structures—including i-motifs (iMs) and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results